CorVel Corp. (NASDAQ:CRVL – Get Free Report) shares hit a new 52-week high on Wednesday. The stock traded as high as $79.43 and last traded at $78.9150, with a volume of 7,907 shares traded. The stock had previously closed at $77.92.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings upgraded CorVel from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, September 1st. One analyst has rated the stock with a Hold rating. Based on data from MarketBeat.com, the company presently has an average rating of “Hold”.
Get Our Latest Analysis on CorVel
CorVel Price Performance
CorVel (NASDAQ:CRVL – Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The business services provider reported $0.63 EPS for the quarter. The business had revenue of $259.93 million for the quarter. CorVel had a net margin of 11.72% and a return on equity of 29.92%.
Insider Buying and Selling at CorVel
In related news, VP Jennifer Yoss sold 2,100 shares of the stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $70.92, for a total transaction of $148,932.00. Following the sale, the vice president directly owned 2,173 shares of the company’s stock, valued at approximately $154,109.16. This represents a 49.15% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director R. Jessup sold 4,023 shares of the firm’s stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $70.07, for a total transaction of $281,891.61. Following the sale, the director owned 111,798 shares in the company, valued at approximately $7,833,685.86. This represents a 3.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 8,947 shares of company stock valued at $630,420. Company insiders own 39.72% of the company’s stock.
Institutional Investors Weigh In On CorVel
A number of institutional investors have recently modified their holdings of CRVL. BlackRock Inc. acquired a new stake in CorVel in the 2nd quarter valued at $321,316,000. Algert Global LLC increased its holdings in CorVel by 67.0% in the 2nd quarter. Algert Global LLC now owns 383,419 shares of the business services provider’s stock worth $23,971,000 after acquiring an additional 153,877 shares in the last quarter. Assenagon Asset Management S.A. increased its holdings in CorVel by 14.7% in the 1st quarter. Assenagon Asset Management S.A. now owns 197,858 shares of the business services provider’s stock worth $10,813,000 after acquiring an additional 25,366 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in CorVel by 0.5% in the 1st quarter. Bank of New York Mellon Corp now owns 184,425 shares of the business services provider’s stock worth $10,079,000 after acquiring an additional 847 shares in the last quarter. Finally, Principal Financial Group Inc. raised its position in CorVel by 8.4% during the first quarter. Principal Financial Group Inc. now owns 179,600 shares of the business services provider’s stock worth $9,815,000 after acquiring an additional 13,938 shares during the period. 51.36% of the stock is currently owned by institutional investors and hedge funds.
CorVel Company Profile
CorVel Corporation is a provider of technology-enabled risk management and healthcare administration services. The company helps employers, insurance carriers, third-party administrators and government entities manage workers’ compensation, auto and liability claims, with an emphasis on controlling costs, coordinating care and improving claim outcomes.
Its services include claims administration, medical bill review, utilization review, case management, pharmacy benefit management, provider-network services and managed-care solutions.
Further Reading
- Five stocks we like better than CorVel
- High Voltage Returns: Navitas Rewires AI Data Centers
- Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
- Albertsons Is Betting on a Turnaround—But Will It Pay Off?
- Venezuela’s Oil Revival Is Gaining Momentum—3 Energy Stocks Positioned to Benefit
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.
